ANNIKA DETHLEFS: Open Payments
NPI 1013627165 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 38 payments from 20 companies in 2025. Trend: 2023 $568 · 2024 $832 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $104 |
| ABBVIE INC. | 4 | $87 |
| PFIZER INC. | 4 | $85 |
| Novo Nordisk Inc | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Exact Sciences Corporation | 2 | $47 |
| Baxter Healthcare | 1 | $45 |
| Lilly USA, LLC | 2 | $39 |
| Agios Pharmaceuticals, Inc. | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
Products named: PREVNAR 20, LEQVIO, Ozempic, QULIPTA, Hillrom - Cardiac Ambulatory Monitor, MOUNJARO, PYRUKYND, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
